September 30, 2025 · Form 4 insider transaction
Ajer Jeffrey Robert bought 8,000 shares of Nektar Therapeutics at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
This stock option vests in substantially equal monthly installments over the one-year period beginning on September 30, 2025.